Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03199846 · ClinicalTrials.gov registry record
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 650
- Enrollment target
NCT03199846 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 650 participants.
The verdict
NCT03199846 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 650 participants
- Enrollment target
Study Summary
This study will collect real-world data from advanced melanoma diagnosis through most recent visit and data sourced from patient medical records following a 2-part study design consisting of a random sample (Part 1) and an oversample (Part 2).
Interventions
- OTHER Non-Interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2016-10-25 |
| Est. Completion | 2017-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03199846
The ClinicalTrials.gov registry entry for NCT03199846 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional is the first listed.
NCT03199846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03199846 about?
NCT03199846 is a clinical study titled "Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States". This study will collect real-world data from advanced melanoma diagnosis through most recent visit and data sourced from patient medical records following a 2-part study design consisting of a random sample (Part 1) and an oversample (Part 2).
What is the current status of trial NCT03199846?
This trial is currently completed. The enrollment target is 650 participants. The study started on 2016-10-25. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT03199846?
The interventions under investigation include: Non-Interventional (OTHER).
Who is sponsoring clinical trial NCT03199846?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.